Tags: High Cholesterol | bad cholesterol | LDL cholesterol | evolocumab | PCSK9

New Once-Monthly Drug Cuts Cholesterol

Monday, 17 Mar 2014 12:35 PM

 


Amgen Inc said on Monday its experimental new type of cholesterol fighter met the primary goal of a late-stage trial by significantly cutting "bad" LDL cholesterol among patients with a genetic tendency towards very high levels of the artery clogging fat.
 
Amgen said patients given its injectable drug evolocumab once a month on top of standard daily statin treatments showed "clinically meaningful" improvement compared to statins alone after 12 weeks of treatment.
 
Evolocumab works by blocking PCSK9, a naturally occurring protein that keeps LDL levels elevated in the bloodstream. Other drugmakers, including Pfizer Inc and a partnership between Regeneron Inc and Sanofi, are racing with Amgen to complete trials of potentially lucrative anti-PCSK9 antibodies.
 
ALERT: 4 Things You'll Feel Before a Heart Attack


© 2015 Thomson/Reuters. All rights reserved.

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Peanut Allergies Cured by Probiotics

Thursday, 29 Jan 2015 13:13 PM

Approximately three million Americans suffer from peanut allergies, which can cause severe respiratory and gastrointesti . . .

Tom Brady Sick on Eve of Super Bowl

Thursday, 29 Jan 2015 13:09 PM

Tom Brady is dealing with a cold four days before the Super Bowl but says he'll be OK. The New England Patriots quarterb . . .

At-Home Sleep Apnea Test Lets You Avoid Night in Clinic

Thursday, 29 Jan 2015 09:38 AM

Until recently, the only way to get tested for sleep apnea was to report for an overnight study at a sleep lab and let a . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved